ATE555801T1 - Behandlung von endothelialer dysfunktion bei diabetes-patienten - Google Patents

Behandlung von endothelialer dysfunktion bei diabetes-patienten

Info

Publication number
ATE555801T1
ATE555801T1 AT07250870T AT07250870T ATE555801T1 AT E555801 T1 ATE555801 T1 AT E555801T1 AT 07250870 T AT07250870 T AT 07250870T AT 07250870 T AT07250870 T AT 07250870T AT E555801 T1 ATE555801 T1 AT E555801T1
Authority
AT
Austria
Prior art keywords
treatment
endothelial dysfunction
diabetes patients
diabetes induced
patient
Prior art date
Application number
AT07250870T
Other languages
English (en)
Inventor
Erik S G Stroes
Original Assignee
Csl Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Ltd filed Critical Csl Ltd
Application granted granted Critical
Publication of ATE555801T1 publication Critical patent/ATE555801T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
AT07250870T 2007-03-01 2007-03-01 Behandlung von endothelialer dysfunktion bei diabetes-patienten ATE555801T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07250870A EP1964571B1 (de) 2007-03-01 2007-03-01 Behandlung von endothelialer Dysfunktion bei Diabetes-Patienten

Publications (1)

Publication Number Publication Date
ATE555801T1 true ATE555801T1 (de) 2012-05-15

Family

ID=38124002

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07250870T ATE555801T1 (de) 2007-03-01 2007-03-01 Behandlung von endothelialer dysfunktion bei diabetes-patienten

Country Status (6)

Country Link
EP (2) EP1964571B1 (de)
AT (1) ATE555801T1 (de)
DK (2) DK2465519T3 (de)
ES (2) ES2442594T3 (de)
HK (2) HK1121938A1 (de)
PL (2) PL1964571T3 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4132954A1 (de) * 2020-04-08 2023-02-15 Institut National de la Santé et de la Recherche Médicale (INSERM) Verwendung von cdon-inhibitoren zur behandlung von endothelialer dysfunktion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002062A1 (en) 1985-10-04 1987-04-09 Biotechnology Research Partners, Ltd. Recombinant apolipoproteins and methods
GB8625435D0 (en) 1986-10-23 1986-11-26 Erba Farmitalia Human apolipoprotein ai
IT1229996B (it) 1989-04-20 1991-09-20 Cesare Sirtori Espressione di apolipoproteina ai e apolipoproteina ai-milano in lievito e composizioni farmaceutiche che contengono dette apolipoproteine.
US5652339A (en) 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins
SE9603303D0 (sv) 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a protein
US6037323A (en) 1997-09-29 2000-03-14 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6004925A (en) 1997-09-29 1999-12-21 J. L. Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
AU2006227133A1 (en) * 2005-03-22 2006-09-28 Georgetown University Delivery systems and methods for diagnosing and treating cardiovascular diseases

Also Published As

Publication number Publication date
DK1964571T3 (da) 2012-08-13
EP1964571B1 (de) 2012-05-02
DK2465519T3 (da) 2014-02-03
EP1964571A1 (de) 2008-09-03
PL2465519T3 (pl) 2014-05-30
EP2465519B1 (de) 2013-10-23
HK1121938A1 (en) 2009-05-08
ES2442594T3 (es) 2014-02-12
HK1171656A1 (en) 2013-04-05
ES2386905T3 (es) 2012-09-05
EP2465519A1 (de) 2012-06-20
PL1964571T3 (pl) 2012-10-31

Similar Documents

Publication Publication Date Title
CY1109321T1 (el) Θεραπεια συνδυασμου για την θεραπεια του διαβητη και των παθησεων συγγενων με αυτον και για την θεραπεια των παθησεων που βελτιωνονται με την αυξηση ενος επιπεδου glp-1 αιματος
EA202091999A2 (ru) Применение ингибиторов dpp iv
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
NZ592516A (en) Antibodies to il-6 and use thereof
NO20082473L (no) Fremgangsmater, sammensetninger og sett for behandling av medisinske tilstander
NO20074943L (no) Roflumilast for behandlingen av diabetes mellitus
ATE407927T1 (de) 3-phenyl-pyrazol-derivate als modulatoren des zur behandlung damit zusammenhängender störungen nützlichen 5-ht-2a-serotonin-rezeptors
ITMO20040191A1 (it) Macchina e metodo per il trattamento extracorporeo di sangue.
ATE486595T1 (de) Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur senkung der lipid- und blutzuckerspiegel
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
EA201101568A1 (ru) Лечение ex vivo иммунологических нарушений с помощью ингибиторов pkc-teta
DE602005015841D1 (de) Aroyl-o-piperidinderivate zur behandlung von problemen im zusammenhang mit diabetes
ATE512948T1 (de) Biphenyl-sulfonyl- und phenyl-heteroaryl-sulfonyl-modulatoren des histamin-h3-rezeptors zur behandlung von damit verbundenen erkrankungen
ATE525070T1 (de) Silbininkomponente zur behandlung von hepatitis
EA201001749A1 (ru) Способ лечения недифференцированного артрита
DK1771415T3 (da) 2-(1H-indolylsulfanyl)-arylaminderivater til anvendelse i behandlingen af affektive sygdomme, smerte, ADHD og stressinkontinens
EA201071146A1 (ru) Способы диагностирования, предупреждения и лечения болезней, связанных с костной массой
CY1110620T1 (el) Μεθοδος θεραπειας οξειας παραρρινοκολπιτιδας
BR0313588A (pt) Métodos para o tratamento da demência com base em apo e genótipo
ATE555801T1 (de) Behandlung von endothelialer dysfunktion bei diabetes-patienten
NO20080495L (no) PEG-IFN-alfa og ribavirin for HBV-behandling
UA29556U (ru) Способ лечения больных острыми вирусными менингитами
UA49068U (ru) Способ лечения больных хроническим некалькулезным| холециститом в сочетании с сахарным диабетом 2-го типа
UA37078U (ru) Способ профилактики рефлюкс-холангита при хирургическом лечении больных с механической желтухой
UA70188C2 (en) Method for treating patients with chronic cardiac insufficiency